Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune
connective-tissue disease. Once considered an untreatable and unpredictable condition …

Systemic sclerosis (SSc; scleroderma) has the highest individual mortality of all rheumatic
diseases, and interstitial lung disease (ILD) is among the leading causes of SSc‐related …

Although interstitial lung disease (ILD) is a leading cause of morbidity and mortality in
patients with inflammatory myopathies, the current definition and diagnostic criteria of …

Objective We provide evidence‐based recommendations regarding screening for interstitial
lung disease (ILD) and the monitoring for ILD progression in people with systemic …

Background Early diffuse cutaneous systemic sclerosis (dcSSc) has the highest case fatality
among rheumatic diseases. We report baseline characteristics, current immunosuppressive …

Systemic sclerosis is a rare and chronic connective tissue disease with a multifaceted
pathogenesis characterised by heterogeneous multi-organ clinical manifestations. Every …

Systemic sclerosis (SSc), the most lethal of rheumatologic conditions, is the cause of death
in> 50% of SSc cases, led by pulmonary fibrosis followed by pulmonary hypertension and …

Systemic sclerosis (SSc), or scleroderma, is a rare, complex, systemic autoimmune disease
of unknown aetiology, characterized by high morbidity and mortality often resulting from …

Systemic sclerosis is the rheumatic disease with the highest individual mortality. The severity
of the disease is determined by the extent of fibrotic changes to cutaneous and internal …

Interstitial lung disease (ILD) frequently complicates the inflammatory myopathies and at
times is the most prominent clinical feature. Over the years, there has been a growing …